In vivo strategies for drug discovery in myotonic dystrophy disorders.
Myotonic dystrophy (DM) is a complex neuromuscular genetic disease for which there is currently no valid therapy. The recent development of non-mammal animal models opened up the possibility of performing drug discovery in vivo, using as screening readout phenotypes with underlying molecular parallels to the disease. In this review we discuss the state of the art technologies already used in large scale drug screening and provide guidance for further development of novel technologies.
Irma
I
Garcia-Alcover
Arturo
A
López Castel
Manuel
M
Perez-Alonso
Ruben
R
Artero
D000818:Animals; D004195:Disease Models, Animal; D055808:Drug Discovery; D006801:Humans; D009223:Myotonic Dystrophy / Q000188:drug therapy*